RESEARCH
Medical Cannabis for Anxiety – Scoping the Evidence .
Interest in medical cannabis for anxiety has grown, with anxiety ranking among the most common reasons for therapeutic use in Canada. Evidence so far remains mixed, prompting a review of randomized trials assessing whether cannabinoids ease anxiety symptoms. Across more than twenty trials involving varied populations—from neuropathic pain to social anxiety—results showed that only a minority reported clear anxiety relief, while most were inconclusive. Studies tested a range of products, including THC, CBD, combinations, and synthetic cannabinoids, each acting differently within the endocannabinoid system. With inconsistent findings and diverse study designs, the overall impact of medical cannabis on anxiety remains uncertain, and a pooled meta-analysis is underway to provide clearer direction.
Already have an account? Log in
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
